Plasma biomarker (673.5, 1.0E-4); dementia risk (672, 1.0E-4); prognostic capabilities (541.39, 1.0E-4); diagnosing dementia (531.4, 1.0E-4); tau PET tracer (531.4, 1.0E-4). This evidence concerns the gene MAPT and dementia.